2025-10-09 - Analysis Report
Okay, here's an analysis of Costco Wholesale Corp (COST), incorporating the provided data. The report is in English with key numbers highlighted, followed by analysis.

**Company Overview:** Costco Wholesale Corp is a membership-only warehouse club that offers a wide variety of merchandise.

## COST Analysis

**1. Performance vs. S&P 500 (VOO)**

*   **COST Cumulative Return:** 208.72%
*   **VOO Cumulative Return:** 99.62%
*   **Absolute Divergence (Current):** 110.4
*   **Divergence Range:** Max 179.3, Min -16.2
*   **Relative Divergence:** 64.8%

**Analysis:** COST has significantly outperformed the S&P 500 over the period in question. The relative divergence of 64.8% indicates that COST's outperformance is in the upper-middle range of its historical divergence from the S&P 500.

Here's a table summarizing the Alpha/Beta Analysis:

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
|------------|---------|--------|---------|--------|--------|
| 2015-2017  | 24.0%   | 65.4%  | -4.0%   | 0.0    | 82.5   |
| 2016-2018  | 15.0%   | 14.9%  | 0.0%    | -0.1   | 90.3   |
| 2017-2019  | 39.0%   | 70.2%  | 17.0%   | 0.4    | 130.3  |
| 2018-2020  | 33.0%   | 80.9%  | 9.0%    | 0.3    | 167.0  |
| 2019-2021  | 89.0%   | 80.9%  | 42.0%   | 0.4    | 251.6  |
| 2020-2022  | 42.0%   | 80.9%  | 42.0%   | 0.4    | 202.3  |
| 2021-2023  | 92.0%   | 80.6%  | 90.0%   | 0.4    | 292.5  |
| 2022-2024  | 110.0%  | 80.6%  | 90.0%   | 0.4    | 406.1  |
| 2023-2025  | 101.0%  | 80.6%  | 37.0%   | 0.4    | 405.4  |

**Analysis:**

*   **CAGR:**  Shows very strong compounded annual growth rates, particularly in recent periods (2019-2025).
*   **MDD:** Maximum Drawdown figures are high, indicating significant price volatility or corrections during those periods.
*   **Alpha:** Demonstrates strong positive alpha in more recent years, signifying that COST has generated returns above what would be expected based on its beta and market returns. The alpha is especially high from 2021-2025.
*   **Beta:** Beta values are consistently around 0.3-0.4, suggesting that COST's price is less sensitive to market movements than the overall market.
*   **Cap(B):**  Market capitalization has shown substantial growth over the years, reflecting the company's increasing value.

**2. Recent Price Action**

*   **Last Price:** 914.8
*   **Previous Close:** 914.8
*   **Change:** 0.0
*   **5-day Moving Average:** 914.54
*   **20-day Moving Average:** 937.08
*   **60-day Moving Average:** 950.73

**Analysis:** The stock price is essentially unchanged at the last market close. The price is currently below both the 20-day and 60-day moving averages, which *could* indicate a short-term downtrend or consolidation phase.

**3. Market Risk Indicators & Expected Return**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 22.65 (Oversold)
*   **PPO:** -0.23
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.70)
*   **Recent (20-day) Relative Divergence Change:** -1.6 (Negative - short-term decline)
*   **Expected Return:** 52.3% (long-term, vs. S&P 500)

**Analysis:**

*   The **MRI** suggests a generally positive investment outlook based on its calculation.
*   The **RSI** indicates that the stock is currently oversold, which *could* suggest a potential buying opportunity if you believe in the company's fundamentals.
*   **PPO** measures the percentage difference between two moving averages (typically 12 and 26 periods). A negative PPO suggests that the shorter-term moving average is below the longer-term moving average, indicating a potential downtrend or weakening momentum.
*   The **Hybrid Signal** recommends deploying 80% of available cash, purchasing 1 share, but advises caution given a MRI of 0.7.
*   The negative change in recent relative divergence aligns with the price being below its moving averages, reinforcing the possibility of short-term weakness.
*   The **Expected Return** indicates a significant potential for long-term outperformance compared to the S&P 500, *if* the factors driving that expectation hold true.
*   The lack of price change between the last price and previous close suggests no major market-moving event in that last session.

**4. Recent News & Significant Events:**

*   Several news items highlight **strong September sales figures** for Costco. This is generally positive.
*   The **recall of a Foster Farms product** is a negative event, although the impact depends on the scale of the recall and consumer reaction.
*   The QSYMIA price reduction at Costco pharmacies is likely a minor positive.
*   Mentions in analyst blogs are generally neutral unless they contain specific rating changes.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-06-05 | 4.29 | 63.20 B$  |
| 2025-03-13 | 4.03 | 63.72 B$  |
| 2024-12-19 | 4.05 | 62.15 B$  |
| 2024-06-06 | 3.79 | 58.52 B$  |
| 2025-06-05 | 3.79 | 58.52 B$  |

**Analysis:**  Both EPS and Revenue have generally been trending upwards over the last several quarters. The most recent EPS figure is particularly strong.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-05-31   | $63.20B   | 12.99%        |
| 2025-02-28   | $63.72B   | 12.52%        |
| 2024-11-30   | $62.15B   | 12.94%        |
| 2024-08-31   | $79.70B   | 12.68%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-05-31   | $27.12B    | 7.02%   |
| 2025-02-28   | $25.58B    | 6.99%   |
| 2024-11-30   | $24.45B    | 7.35%   |
| 2024-08-31   | $23.62B    | 9.97%   |

**Analysis:**

*   **Revenue:** Revenue has fluctuated, with the $79.70B figure in 2024-08-31 being significantly higher than the other quarters.  This could be due to seasonal factors or other specific events during that period.
*   **Profit Margin:** Profit margins have remained relatively stable around 12.5-13%.
*   **Equity:** Equity has been steadily increasing, indicating growth in the company's net assets.
*   **ROE:** Return on Equity has fluctuated but generally remained strong. The higher ROE in 2024-08-31 corresponds with the higher revenue in that quarter.

**7. Summary and Conclusion**

Overall, the analysis paints a mixed but generally positive picture for Costco (COST).

*   **Strengths:** Strong historical outperformance vs. the S&P 500, high recent CAGR and Alpha, generally positive sales news, analyst consensus leans towards "Buy", growing revenue and equity.
*   **Weaknesses/Concerns:** Recent price weakness (below moving averages), oversold RSI *might* suggest a short-term bounce, but also could be a sign of further decline, the product recall is a negative, although the impact is uncertain.
*   **Moving Forward:** Focus on managing the costs and consumer reaction related to the product recall. Maintain steady growth in sales, profit margins, and ROE.

The current situation might present a possible long-term investment opportunity for those who believe in Costco's business model and long-term growth potential, considering the MRI and expected return. However, the short-term price action suggests caution.

**Disclaimer:** This is an AI-generated analysis and is not financial advice. Please consult with a qualified financial advisor before making any investment decisions.
